Elevation Wealth Partners
WST icon

Elevation Wealth Partners’s West Pharmaceutical WST Stock Holding History

Elevation Wealth Partners’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$78.2K Buy
211
+78
+59% +$27.5K 0.02% 251
2026
Q2 		$47.7K Buy
133
+124
+1,378% +$37.9K 0.01% 312
2026
Q1 		$2.26K Sell
9
-8
-47% -$1.99K ﹤0.01% 886
2025
Q4 		$4.68K Buy
17
+3
+21% +$821 ﹤0.01% 643
2025
Q3 		$3.67K Buy
+14
New +$3.4K ﹤0.01% 532

Other funds holding WST

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Border to Coast Pensions Partnership
Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return

Elevation Wealth Partners's WST Position: Q3 2026 in Review

Elevation Wealth Partners increased its West Pharmaceutical (WST) stake by 59% in Q3 2026, buying an estimated $27.5K and bringing the position to 211 shares worth $78.2K. The position accounts for 0.02% of the portfolio, ranked #251.

Elevation Wealth Partners first reported a position in WST in Q3 2025 and has held it in 5 quarters since. 430 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • Elevation Wealth Partners held 211 shares of West Pharmaceutical worth $78.2K as of Q3 2026.
  • Elevation Wealth Partners bought 78 West Pharmaceutical shares in Q3 2026, an estimated $27.5K.
  • West Pharmaceutical made up 0.02% of Elevation Wealth Partners's portfolio in Q3 2026, its #251 holding.
  • Elevation Wealth Partners first reported a position in West Pharmaceutical in Q3 2025 and has held it in 5 quarters since.
  • 430 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Elevation Wealth Partners's 13F filing for Q3 2026, filed 7 Oct 2026.